A new study hints at the cure potential for an intrauterine contraceptive device (IUD) to treat young women with early stage endometrial cancer without compromising their fertility.
Results from the prospective study, carried out by researchers at the European Institute of Oncology in Italy, showed that almost 60 percent of the women with well-differentiated endometrial cancer had a complete response to a treatment that included the implanting of an IUD that contains the progestin levonorgestrel followed by six months of gonadotropin-releasing hormone therapy.
This presents the potential for a much more appealing treatment than a hysterectomy.
Endometrial cancer is the sixth most common cancer among women worldwide, with about 290,000 new diagnoses every year.
CANCER TYPE(S)
Endometrial cancer
TREATMENT TYPE(S)
Intrauterine contraceptive device
WHERE WAS THIS STUDY PUBLISHED?
Annals of Oncology
Source
MedPageToday
